-
Uridine, Trisodium Salt in Cell Assays
2026-08-25
Learn how Uridine, Trisodium Salt (SKU B1473) can be incorporated into cell viability, proliferation, cytotoxicity, and RNA metabolism studies without obscuring assay interpretation. This scenario-driven guide covers controls, solubility, stock preparation, storage, data analysis, and practical supplier selection.
-
Exercise, Muscle EVs, and Microglial Aβ Clearance
2026-08-24
A 2026 Nature Aging study identifies skeletal muscle-derived extracellular vesicles as mediators of exercise-related benefits in Alzheimer’s disease mice. The work links swimming-induced vesicle release to microglial plaque clearance and implicates miR-378a-3p–dependent lipid-metabolism regulation as a potential exercise-mimicking therapeutic mechanism.
-
Z-WEHD-FMK for Caspase-1 Pathway Studies
2026-08-24
Z-WEHD-FMK enables time-controlled inhibition of inflammatory caspases in pyroptosis, cancer-cell signaling, and pathogen-inclusion models. This practical guide connects the HOXC8–caspase-1 findings in lung cancer with dose planning, orthogonal readouts, and troubleshooting for inflammation research and infectious disease research.
-
VX-765: A Mechanistic Guide to Pyroptosis Assays
2026-08-23
VX-765 and its active metabolite VRT-043198 provide a focused way to test caspase-1-dependent inflammation and pyroptosis. This guide translates endothelial oxidative-stress research into practical assay design, interpretation, and cross-model decision-making.
-
Cabozantinib (XL184) RCC Workflow Guide
2026-08-22
Cabozantinib (XL184) supports more than short-term kinase inhibition: it enables paired acute and chronic renal cell carcinoma experiments that reveal time-dependent signaling adaptation. This workflow combines phosphoproteomics, site-specific validation, angiogenesis assays, and motility testing while emphasizing solvent control and interpretation of chronic exposure data.
-
SLC11A1–TGF-β1 Signaling in Colorectal Cancer
2026-08-21
Yang and colleagues identify SLC11A1 as a colorectal cancer-associated factor that promotes proliferation, migration, and invasion while reducing cellular susceptibility to ferroptosis. Their data connect SLC11A1 with TGF-β1/Smad2/3 signaling and provide a mechanistic basis for studying ferroptosis resistance, although further rescue and in vivo experiments are needed to establish therapeutic relevance.
-
Calpeptin Workflows for Fibrosis and EV Research
2026-08-20
Calpeptin is a nanomolar calpain inhibitor for dissecting calcium-dependent proteolysis in fibroblast activation, inflammatory signaling, and extracellular-vesicle biology. This guide connects fibrosis assays with an orthogonal EV-release workflow while emphasizing controls, solvent handling, normalization, and interpretation limits.
-
Spiroplasma Entry into Drosophila S2 Cells
2026-08-20
Wei et al. established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris both damages host cells and actively enters them through clathrin-mediated endocytosis and macropinocytosis. The study combines pharmacological inhibition, cytoskeletal perturbation, microscopy, and intracellular bacterial quantification to define an entry process relevant to invertebrate infection biology.
-
S63845: MCL1 Dependency in Translational Apoptosis
2026-08-19
S63845 provides a selective way to interrogate MCL1 dependency, mitochondrial apoptosis, and residual disease biology. This thought-leadership perspective connects mechanistic evidence from chemotherapy-induced senescence with practical assay design and translational strategy in hematological cancer research.
-
Pravastatin sodium: Assay Workflows and Optimization
2026-08-19
Build reproducible cholesterol, macrophage, and hepatocyte assays with Pravastatin sodium, an HMG-CoA reductase inhibitor suited to concentration-response and transporter-aware study designs. The workflow combines pathway-specific readouts with viability controls to distinguish cholesterol biosynthesis inhibition from nonspecific cellular stress.
-
Dual Metabolic Reprogramming in TNBC Ferroptosis
2026-08-18
The reference study identifies a previously overlooked trade-off in brequinar-mediated ferroptosis: DHODH inhibition can sensitize tumor cells to oxidative death while increasing lipid-droplet accumulation that reinforces resistance. Its AB@HA-TA/Fe nanoplatform co-delivers brequinar and the DGAT1 inhibitor A922500, producing dual metabolic intervention and antitumor activity in 4T1 models in vitro and in vivo.
-
Self-Amplifying RNA for Dose-Sparing Influenza Vaccines
2026-08-18
This study directly compares nucleoside-modified mRNA, self-amplifying RNA, and circular RNA vaccines across seasonal influenza subtypes. Its central finding is that a low-dose trivalent self-amplifying RNA formulation overcame the weak influenza B response observed with conventional mRNA and produced durable protection in mice.
-
From ROS Signal to Mechanism: DCFH-DA in PCOS
2026-08-17
A translational framework for using 2,7-Dichlorodihydrofluorescein diacetate and DCFH-DA to connect oxidative-stress measurements with granulosa-cell biology, pathway validation, and therapeutic decision-making in PCOS research.
-
FPH1 (BRD-6125) Hepatocyte Workflow Guide
2026-08-17
FPH1 (BRD-6125) supports a practical route to expanding functional human hepatocytes while tracking proliferation and liver-specific performance in parallel. This guide connects primary human hepatocyte culture and iPS-derived hepatocyte workflows with quantitative readouts, compound-handling controls, and a carefully bounded perspective on optogenetic gene-regulation research.
-
Omeprazole A2845: H+,K+-ATPase Protocol
2026-08-16
Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for gastric acid secretion research, assay development, and antiulcer activity study workflows. It is intended for controlled scientific experiments only, not for diagnosis, treatment, or direct medical use, and its aqueous handling is limited by poor water solubility.